Based in WI Harper Taipei office, Ms. Joyce Lee is a Principal with years of expertise and hands-on experience in Healthcare, Consumer and Enterprise TMT sectors. At present, she works with our investment team to scout for new ventures and manage our key portfolio companies.
In 2013, Ms. Lee was invited to join Diamond Biofund, a $260 Million-dollar evergreen healthcare-focused fund supported by renowned Taiwanese Financial Holdings and Biotech Group. At Diamond BioFund, she specialized investment assets and companies in new drug development and pharmaceutical sector. Ms. Lee successfully led several investments across China and Taiwan and participated actively in portfolio management and served as board directors.
Ms. Lee joined Yuanta Financial Holdings in 2008 as an equity analyst at the Yuanta Securities and covered Healthcare and Finance industry. Yuanta is a leading Investment Bank in Greater China area and has been ranked among the top 10 “Best Regional Research” by Asia Money in consecutive years. In her years at Yuanta, Ms. Lee gained practical perspective and tremendous insight in the healthcare industry and capital market.
Ms. Lee holds a B.A. degree in Political Science, and minor in Economics, MBA in International Business from National Cheng Kung University.
WI Harper Group
Founded in 1993, WI Harper Group is one of the founding venture capital franchises. The firm pioneered the investment strategy of creating a value-added bridge between the United States and Greater China and has invested in leading technology and healthcare companies with aspirations to become global leaders. WI Harper Group is an active partner with a track record of over 400 investments in technology, and it manages more than $1 billion in committed capital from offices in San Francisco, Beijing, and Taipei.
Through WI Harper Group, we build a “bridge model” that seamlessly connects Taiwan’s technology industry’s rich foundation with Silicon Valley’s cutting-edge technologies. WI Harper Group aims to enhance investments and strategic positioning in Taiwanese startups, creating more successful cases that align with the international market.